Although the science behind tissue support matrix cell therapy for joint and spine pain is still young, it holds much promise.
Tissue support matrix cells can be isolated from the bone marrow of the iliac crest or abdominal fat or obtained from a laboratory source. They contain genetic material that stimulates the cells of injured tissue.
Biological research is advancing rapidly. Current exogenous sources are using human birth tissue bioavailable materials, mesenchymal cells, and Extracellular vesicles to treat a variety of different conditions.
Cells extracted from the individual can now be made more potent with the addition of ozone and various peptides.
Preconditioning for Tissue Support Matrix Cell Therapy is an important step that allows the person receiving treatment to be optimized. When the body is optimized, the matrix cells are more active and the results of the therapy are more effective.
OWM Preconditioning program includes 3 days of intravenous infusions of essential nutrition molecules and intravenous Ozone therapy.
Tissue support matrix cells are an abundant source of self-renewing, multi-potent undifferentiated cells that can be readily isolated from bone marrow and adipose tissue. These cells can then differentiate into bone, cartilage, fat, and tendon. Their use has been steadily growing for support of injured tissues in the body. These cells in addition to their differentiation potential, exhibit a growth-promoting, and immune-mediating activity shown to attenuate the mediators of joint and tissue destruction.
The tissue support matrix cell therapy has numerous applications.
Please contact our office directly to discuss how this therapy can help you.
Tissue Support Matrix Cells are potent cells that can be gently extracted from either your bone marrow or your abdominal fat or can be cultured in a lab.
They are versatile; able to support many different tissues and structures in the body.
Tissue Support Matrix cells cultured in a lab may be a better option in cases of chronic illness where the body’s cells are not potent enough.
Tissue support matrix cells are injected with ultrasound guidance to the areas of tissue injury and degeneration.
Some preparations can also be infused intravenously.
A survey of 2,800 patients across multiple studies demonstrated a complication rate of less than 0.17%— less than the complication rate of Ibuprofen.
Tissue support matrix cells that are obtained from the person being treated do not pose any risk of rejection or an autoimmune response.
Exogenous or lab-cultured tissue support matrix cells are excretion products. They are cultured and harvested in a sterile lab environment and do not cause an autoimmune response and are very well tolerated.